Clinicians recommended adopting a holistic approach for patients with CKD representing a barometer of overall health. Conclusions The introduction of new National Institute for Health and Care ...

More information: Kim Ngan Tran et al, New composite phenotypes enhance chronic kidney disease classification and genetic associations, PLOS Genetics (2025). DOI: 10.1371/journal.pgen.1011718 ...

Tens of thousands of people with chronic kidney disease in England could be eligible for treatment with AstraZeneca's SGLT2 inhibitor Forxiga, after NICE backed NHS use of the drug in draft ...

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease. pharmaphorum caught up with AZ’s Joris Silon to discuss ...

The study is titled "New composite phenotypes enhance chronic kidney disease classification and genetic associations." "Chronic kidney disease (CKD) can result from diverse underlying causes ...

Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE. People in England will become the first in ...

Stage One runner up, Olympic and USA national champion Kristen Faulkner, finished in the lead chasing group and now tops the General Classification table, four seconds ahead of Riejanne Markus.

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga (dapagliflozin) as an option to treat chronic ...

Patients with chronic kidney disease and end-stage renal disease are at 5- to 10-fold higher risk for developing cardiovascular disease (CVD) than age-matched controls. Clinically, CVD in this ...